Home
Conditions
Growth Disorders

Clinical trial condition

Growth Disorders

Explore clinical trials studying Growth Disorders. Study availability and eligibility vary by location and protocol.

48 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Growth Disorders trial results

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea

NCT01259778

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Yonsei University Colleage of Medicine, Severance Hospital Seoul, South Korea

View Trial Details

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina

NCT01582334

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: For Recruiting Locations in Argentina Please Contact the Merck KGaA Communication Center, Argentina

View Trial Details

Completed

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment

NCT01438528

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: For Recruiting Locations in China Please Contact the Merck KGaA Communication Center, China

View Trial Details

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain

NCT01376921

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: For Recruiting Locations in Spain Please Contact the Merck KGaA Communication Center, Spain

View Trial Details

Completed

A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment

NCT01267526

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Merck Serono Research Site Calgary, Alberta, Canada

Merck Serono Research Site Edmonton, Alberta, Canada

Merck Serono Research Site North Vancouver, British Columbia, Canada

Merck Serono Research Site Vancouver, British Columbia, Canada

View Trial Details

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East

NCT02015286

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: For Recruiting Locations in the United Arab Emirates and the Kingdom of Saudi Arabia Please Contact the Merck KGaA Communication Center, Darmstadt, Germany

View Trial Details

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia

NCT02208076

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: For Recruiting Locations in Colombia Please Contact the Merck KGaA Communication Center, Colombia

View Trial Details

Completed

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic

NCT01400997

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: For Recruiting Locations in Czech Republic Please Contact the Merck KGaA Communication Center, Czechia

View Trial Details

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France

NCT01291394

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: Contact Merck KGaA Communication Center, France

View Trial Details

Completed

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia

NCT01400984

Conditions: Growth Disorders, Pathologic Processes, Pathological Conditions, Signs and Symptoms
Locations: For Recruiting Locations in Slovakia Please Contact the Merck KGaA Communication Center, Slovakia

View Trial Details

Growth Disorders

Growth Disorders trial results

Related conditions